- Home
- OBK vs KURA Comparison
OBK vs KURA Comparison
Compare OBK & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBK
- KURA
- Stock Information
- Founded
- OBK 1912
- KURA 2014
- Country
- OBK United States
- KURA United States
- Employees
- OBK N/A
- KURA N/A
- Industry
- OBK Major Banks
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OBK Finance
- KURA Health Care
- Exchange
- OBK Nasdaq
- KURA Nasdaq
- Market Cap
- OBK 1.0B
- KURA 1.0B
- IPO Year
- OBK 2018
- KURA N/A
- Fundamental
- Price
- OBK $36.93
- KURA $12.08
- Analyst Decision
- OBK Strong Buy
- KURA Buy
- Analyst Count
- OBK 8
- KURA 11
- Target Price
- OBK $43.00
- KURA $25.00
- AVG Volume (30 Days)
- OBK 143.6K
- KURA 2.2M
- Earning Date
- OBK 10-22-2025
- KURA 11-04-2025
- Dividend Yield
- OBK 1.64%
- KURA N/A
- EPS Growth
- OBK N/A
- KURA N/A
- EPS
- OBK 1.91
- KURA N/A
- Revenue
- OBK $325,588,000.00
- KURA $104,029,000.00
- Revenue This Year
- OBK $13.27
- KURA $68.63
- Revenue Next Year
- OBK $6.08
- KURA $141.59
- P/E Ratio
- OBK $19.12
- KURA N/A
- Revenue Growth
- OBK N/A
- KURA N/A
- 52 Week Low
- OBK $28.80
- KURA $5.41
- 52 Week High
- OBK $41.17
- KURA $12.49
- Technical
- Relative Strength Index (RSI)
- OBK 64.74
- KURA 66.94
- Support Level
- OBK $32.28
- KURA $10.86
- Resistance Level
- OBK $35.68
- KURA $11.88
- Average True Range (ATR)
- OBK 0.99
- KURA 0.88
- MACD
- OBK 0.23
- KURA 0.08
- Stochastic Oscillator
- OBK 97.14
- KURA 85.86
About OBK Origin Bancorp Inc.
Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.